Bank of Nova Scotia »

Theravance Biopharma shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2025-12-31 $199k 11k 18.71
2022-03-31 $207k 22k 9.56
2021-12-31 $282k 26k 11.07

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Key (KEY)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Cibc Cad (CM)
Micron Technology (MU)
Tesla Motors (TSLA)

View all positions for Bank of Nova Scotia

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma